Cartalax
ExperimentalBioregulator / Research-onlyExperimental
Cartilage bioregulator for joint longevity; Russian research.
For research use only.
Key Facts
- CAS
- Not available
- Molecular Weight (MW)
- 317.3 g/mol
- Half-life
- Short (hours)
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- Daily
- Last updated
- 12/18/2025
- Targets
- FibroblastsECM
Overview
Cartilage bioregulator for joint longevity; Russian research.
Protocol
- Dosage Range
- 2-5 mg per day
- Frequency
- Daily
- Cycle
- 4-6 weeks on, 4-6 off
- Administration Route
- Subcutaneous
- Reconstitution Guide
- 3 mL BAC water for 25 mg vial
Science
Mechanism of Action
Modulates fibroblast gene expression, inhibits MMP-9.
Targets
FibroblastsECM
Studies
- — Journal/year not available
Benefits
Joint longevityCartilage preservationMobility supportStructural resilience
Potential Side Effects
- None common
- Mild GI upset (rare)